CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database

Distribution of CYP2C9*13 allele in the Chinese Han and the long-range haplotype containing CYP2C9*13 and CYP2C19*2

(2012) Dayong Si et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Allele and Genotype Frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese Populations

(2012) Liang Jin Zuo et al.   Genetic Testing and Molecular Biomarkers

Genetic polymorphisms are associated with variations in warfarin maintenance dose in Han Chinese patients with venous thromboembolism

(2012) Wei Zhang et al.   PHARMACOGENOMICS

In Vitro Assessment of the Allelic Variants of Cytochrome P450

(2011) Masahiro Hiratsuka   Drug Metabolism and Pharmacokinetics

Population Differences in Major Functional Polymorphisms of Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans: Implications in the Clinical Trials for Novel Drug Development

(2011) Kouichi Kurose et al.   Drug Metabolism and Pharmacokinetics

Frequency of CYP2C9 variant alleles, including CYP2C9*13 in a Korean population and effect on glimepiride pharmacokinetics

(2011) H. W. Lee et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Integrating interacting drugs and genetic variations to improve the predictability of warfarin maintenance dose in Chinese patients

(2011) Shi-Long Zhong et al.   Pharmacogenetics and Genomics

New genetic variant that might improve warfarin dose prediction in African Americans

(2010) Hedi Schelleman et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population

(2010) Yan Shi et al.   FORENSIC SCIENCE INTERNATIONAL

Microarray-Based Detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 Allele Frequencies in Native Russians

(2010) Olga Gra et al.   Genetic Testing and Molecular Biomarkers

A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China

(2010) Yuyu Xiong et al.   GENOMICS

CombinedCYP2C9,VKORC1andCYP4F2frequencies among racial and ethnic groups

(2010) Stuart A Scott et al.   PHARMACOGENOMICS

Interethnic differences of CYP2C9 alleles in healthy Hungarian and Roma population samples: Relationship to worldwide allelic frequencies

(2009) Csilla Sipeky et al.   BLOOD CELLS MOLECULES AND DISEASES

Genetic Polymorphism of the Human Cytochrome P450 2C9 Gene and Its Clinical Significance

(2009) Bo Wang et al.   CURRENT DRUG METABOLISM

Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development

(2009) S.-F. Zhou et al.   CURRENT MEDICINAL CHEMISTRY

Polymorphism of human cytochrome P450 enzymes and its clinical impact

(2009) Shu-Feng Zhou et al.   DRUG METABOLISM REVIEWS

Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population

(2009) Hui-Hung Wang et al.   PHARMACOGENOMICS

ARMS test for diagnosis ofCYP2C9andVKORC1mutation in patients with pulmonary embolism in Han Chinese

(2009) Jin Zhu et al.   PHARMACOGENOMICS

Prevalence of CYP2C9 polymorphisms in the south of Europe

(2009) Paula Sánchez-Diz et al.   PHARMACOGENOMICS JOURNAL

Effects of theCYP2C9*13allele on the pharmacokinetics of losartan in healthy male subjects

(2009) Z. Li et al.   XENOBIOTICA

Genetic Variations of CYP2C9 in 724 Japanese Individuals and Their Impact on the Antihypertensive Effects of Losartan

(2008) Tong YIN et al.   HYPERTENSION RESEARCH

A secreted luciferase for ex vivo monitoring of in vivo processes

(2008) Thomas Wurdinger et al.   NATURE METHODS